83 related articles for article (PubMed ID: 16822589)
1. Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system.
Vinod KY; Yalamanchili R; Xie S; Cooper TB; Hungund BL
Neurochem Int; 2006 Nov; 49(6):619-25. PubMed ID: 16822589
[TBL] [Abstract][Full Text] [Related]
2. Nest building is a novel method for indexing severity of alcohol withdrawal in mice.
Greenberg GD; Huang LC; Spence SE; Schlumbohm JP; Metten P; Ozburn AR; Crabbe JC
Behav Brain Res; 2016 Apr; 302():182-90. PubMed ID: 26795092
[TBL] [Abstract][Full Text] [Related]
3. A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.
Pava MJ; Woodward JJ
Alcohol; 2012 May; 46(3):185-204. PubMed ID: 22459871
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids: getting the message across.
Alger BE
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8512-3. PubMed ID: 15173576
[No Abstract] [Full Text] [Related]
5. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers.
Hirvonen J; Goodwin RS; Li CT; Terry GE; Zoghbi SS; Morse C; Pike VW; Volkow ND; Huestis MA; Innis RB
Mol Psychiatry; 2012 Jun; 17(6):642-9. PubMed ID: 21747398
[TBL] [Abstract][Full Text] [Related]
6. Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence.
Ceccarini J; Hompes T; Verhaeghen A; Casteels C; Peuskens H; Bormans G; Claes S; Van Laere K
J Neurosci; 2014 Feb; 34(8):2822-31. PubMed ID: 24553924
[TBL] [Abstract][Full Text] [Related]
7. Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake.
Serrano A; Pavon FJ; Buczynski MW; Schlosburg J; Natividad LA; Polis IY; Stouffer DG; Zorrilla EP; Roberto M; Cravatt BF; Martin-Fardon R; Rodriguez de Fonseca F; Parsons LH
Neuropsychopharmacology; 2018 Aug; 43(9):1840-1850. PubMed ID: 29748627
[TBL] [Abstract][Full Text] [Related]
8. Alcohol-Endocannabinoid Interactions: Implications for Addiction-Related Behavioral Processes.
Serrano A; Natividad LA
Alcohol Res; 2022; 42(1):09. PubMed ID: 35655710
[TBL] [Abstract][Full Text] [Related]
9. Alcohol Use Disorder: Neurobiology and Therapeutics.
Yang W; Singla R; Maheshwari O; Fontaine CJ; Gil-Mohapel J
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625928
[TBL] [Abstract][Full Text] [Related]
10. The Synaptic Interactions of Alcohol and the Endogenous Cannabinoid System.
Wolfe SA; Vozella V; Roberto M
Alcohol Res; 2022; 42(1):03. PubMed ID: 35223337
[TBL] [Abstract][Full Text] [Related]
11. Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP).
Marszalek-Grabska M; Smaga I; Surowka P; Grochecki P; Slowik T; Filip M; Kotlinska JH
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360704
[TBL] [Abstract][Full Text] [Related]
12. CB1 receptor neutral antagonist treatment epigenetically increases neuropeptide Y expression and decreases alcohol drinking.
Dulman RS; Zhang H; Banerjee R; Krishnan HR; Dong B; Hungund BL; Vinod KY; Pandey SC
Neuropharmacology; 2021 Sep; 195():108623. PubMed ID: 34048869
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Fatty Acid Amide Hydrolase to Alcohol Use Disorder: A Systematic Review.
Niemela G; Terry GE
Cannabis Cannabinoid Res; 2021 Apr; 6(2):105-118. PubMed ID: 33989054
[No Abstract] [Full Text] [Related]
14. Traumatic Stress, Chronic Ethanol Exposure, or the Combination, Alter Cannabinoid System Components in Reward and Limbic Regions of the Mouse Brain.
Piggott VM; Lloyd SC; Matchynski JI; Perrine SA; Conti AC
Molecules; 2021 Apr; 26(7):. PubMed ID: 33917316
[TBL] [Abstract][Full Text] [Related]
15. Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.
Koob GF
Pharmacol Rev; 2021 Jan; 73(1):163-201. PubMed ID: 33318153
[TBL] [Abstract][Full Text] [Related]
16. Intermittent ethanol exposure during adolescence impairs cannabinoid type 1 receptor-dependent long-term depression and recognition memory in adult mice.
Peñasco S; Rico-Barrio I; Puente N; Fontaine CJ; Ramos A; Reguero L; Gerrikagoitia I; de Fonseca FR; Suarez J; Barrondo S; Aretxabala X; García Del Caño G; Sallés J; Elezgarai I; Nahirney PC; Christie BR; Grandes P
Neuropsychopharmacology; 2020 Jan; 45(2):309-318. PubMed ID: 31569197
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder.
Bedse G; Centanni SW; Winder DG; Patel S
Alcohol Clin Exp Res; 2019 Oct; 43(10):2014-2027. PubMed ID: 31373708
[TBL] [Abstract][Full Text] [Related]
18. Distinct functions of endogenous cannabinoid system in alcohol abuse disorders.
Basavarajappa BS; Joshi V; Shivakumar M; Subbanna S
Br J Pharmacol; 2019 Sep; 176(17):3085-3109. PubMed ID: 31265740
[TBL] [Abstract][Full Text] [Related]
19. Medical Use of Cannabinoids.
Fraguas-Sánchez AI; Torres-Suárez AI
Drugs; 2018 Nov; 78(16):1665-1703. PubMed ID: 30374797
[TBL] [Abstract][Full Text] [Related]
20. Silencing synaptic MicroRNA-411 reduces voluntary alcohol consumption in mice.
Most D; Salem NA; Tiwari GR; Blednov YA; Mayfield RD; Harris RA
Addict Biol; 2019 Jul; 24(4):604-616. PubMed ID: 29665166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
